Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Targeting the MAPK Signaling Pathway in Cancer: Promising Preclinical Activity With the Novel Selective ERK1/2 Inhibitor BVD-523 (Ulixertinib)
Molecular Cancer Therapeutics
Cancer Research
Oncology
Epigenetic Regulation of NAMPT by NAMPT-AS Drives Metastatic Progression in Triple-Negative Breast Cancer
Cancer Research
Cancer Research
Oncology
Evaluation of the Novel Mitotic Modulator ON 01910.Na in Pancreatic Cancer and Preclinical Development of an Ex Vivo Predictive Assay
Oncogene
Cancer Research
Genetics
Molecular Biology
A PARP Inhibitor in Pancreatic Cancer: Enhancement Anti-Tumour Activity of Chemoradiation Therapy Against Pancreatic Cancer?
EBioMedicine
Biochemistry
Medicine
Genetics
Molecular Biology
Antitumor Activity and Molecular Effects of the Novel Heat Shock Protein 90 Inhibitor, IPI-504, in Pancreatic Cancer
Molecular Cancer Therapeutics
Cancer Research
Oncology
The MEK1/2 Inhibitor Pimasertib Enhances Gemcitabine Efficacy in Pancreatic Cancer Models by Altering Ribonucleotide Reductase Subunit-1 (RRM1)
Clinical Cancer Research
Cancer Research
Oncology
Preclinical Development of Targeted Stereotactic Body Radiation Therapy for Pancreatic Cancer
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
Evaluating Preclinical Efficacy
Science Translational Medicine
Medicine
Targeting the Warburg Effect With a Novel Glucose Transporter Inhibitor to Overcome Gemcitabine Resistance in Pancreatic Cancer Cells
Carcinogenesis
Medicine
Cancer Research
Activity of PXD101, a Histone Deacetylase Inhibitor, in Preclinical Ovarian Cancer Studies
Molecular Cancer Therapeutics
Cancer Research
Oncology
‹
1
2
3
4
5
6
7
›
